UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 53

Sortiert nach

Low-frequency MR elastography reveals altered deep gray matter viscoelasticity in multiple sclerosis

NeuroImage clinical, 2024-01, Vol.42, p.103606-103606, Article 103606

2024

Link zum Volltext

Verfügbarkeit prüfen

Smelling multiple sclerosis: Different qualities of olfactory function reflect either inflammatory activity or neurodegeneration

Multiple sclerosis, 2020-01, Vol.26 (1), p.57-68

2020

Link zum Volltext

Verfügbarkeit prüfen

Experiences in treatment of multiple sclerosis with natalizumab from a real-life cohort over 15 years

Scientific reports, 2021-12, Vol.11 (1), p.23317-23317, Article 23317

2021

Link zum Volltext

Verfügbarkeit prüfen

Change of olfactory function as a marker of inflammatory activity and disability progression in MS

Multiple sclerosis, 2019-02, Vol.25 (2), p.267-274

2019

Link zum Volltext

Verfügbarkeit prüfen

Immune profiling in multiple sclerosis: a single-center study of 65 cytokines, chemokines, and related molecules in cerebrospinal fluid and serum

Frontiers in immunology, 2023-06, Vol.14, p.1200146-1200146

2023

Link zum Volltext

Verfügbarkeit prüfen

Influence of physical activity on serum vitamin D levels in people with multiple sclerosis

PloS one, 2020-06, Vol.15 (6), p.e0234333-e0234333

2020

Link zum Volltext

Verfügbarkeit prüfen

Cerebrospinal fluid B cells and disease progression in multiple sclerosis - A longitudinal prospective study

PloS one, 2017-08, Vol.12 (8), p.e0182462-e0182462

2017

Link zum Volltext

Verfügbarkeit prüfen

Paroxysmal and unusual symptoms as first clinical manifestation of multiple sclerosis do not indicate benign prognosis-The PaSiMS II study

PloS one, 2017-07, Vol.12 (7), p.e0181458-e0181458

2017

Link zum Volltext

Verfügbarkeit prüfen

Impact of Disease-Modifying Treatments on the Longitudinal Evolution of Anti-JCV Antibody Index in Multiple Sclerosis

Frontiers in immunology, 2018-10, Vol.9, p.2435-2435

2018

Link zum Volltext

Verfügbarkeit prüfen

Transient impairment of olfactory threshold in acute multiple sclerosis relapse

Multiple sclerosis and related disorders, 2018-07, Vol.23, p.74-77

2018

Link zum Volltext

Verfügbarkeit prüfen

Distinct serum and cerebrospinal fluid cytokine and chemokine profiles in autoantibody-associated demyelinating diseases

Multiple sclerosis journal - experimental, translational and clinical, 2019-04, Vol.5 (2), p.2055217319848463-2055217319848463

2019

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of a self-administered iPad®-based processing speed assessment for people with multiple sclerosis in a clinical routine setting

Journal of neurology, 2024-06, Vol.271 (6), p.3268-3278

2024

Link zum Volltext

Verfügbarkeit prüfen

Pregnancy and multiple sclerosis in the DMT era: A cohort study in Western Austria

Multiple sclerosis, 2020-01, Vol.26 (1), p.69-78

2020

Link zum Volltext

Verfügbarkeit prüfen

Peripapillary retinal nerve fibre layer as measured by optical coherence tomography is a prognostic biomarker not only for physical but also for cognitive disability progression in multiple sclerosis

Multiple sclerosis, 2019-02, Vol.25 (2), p.196-203

2019

Link zum Volltext

Verfügbarkeit prüfen

Macular ganglion cell–inner plexiform layer thinning as a biomarker of disability progression in relapsing multiple sclerosis

Multiple sclerosis, 2021-04, Vol.27 (5), p.684-694

2021

Link zum Volltext

Verfügbarkeit prüfen

Psychological factors and brain magnetic resonance imaging metrics associated with fatigue in persons with multiple sclerosis

Journal of the neurological sciences, 2023-11, Vol.454, p.120833-120833, Article 120833

2023

Link zum Volltext

Verfügbarkeit prüfen

Impairment of odor discrimination and identification is associated with disability progression and gray matter atrophy of the olfactory system in MS

Multiple sclerosis, 2020-05, Vol.26 (6), p.706-715

2020

Link zum Volltext

Verfügbarkeit prüfen

Serum neurofilament levels correlate with retinal nerve fiber layer thinning in multiple sclerosis

Multiple sclerosis, 2020-11, Vol.26 (13), p.1682-1690

2020

Link zum Volltext

Verfügbarkeit prüfen

Retinal layer thinning predicts treatment failure in relapsing multiple sclerosis

European journal of neurology, 2021-06, Vol.28 (6), p.2037-2045

2021

Link zum Volltext

Verfügbarkeit prüfen

Quantifying the risk of disease reactivation after interferon and glatiramer acetate discontinuation in multiple sclerosis: The VIAADISC score

European journal of neurology, 2021-05, Vol.28 (5), p.1609-1616

2021

Link zum Volltext

Verfügbarkeit prüfen

Olfactory threshold predicts treatment response in relapsing multiple sclerosis

Multiple sclerosis, 2022-09, Vol.28 (10), p.1541-1552

2022

Link zum Volltext

Verfügbarkeit prüfen

Late-onset neutropenia in a multiple sclerosis patient after first dose ocrelizumab switched from rituximab

Multiple sclerosis and related disorders, 2020-08, Vol.43, p.102155-102155, Article 102155

2020

Link zum Volltext

Verfügbarkeit prüfen

Smoking is not associated with higher prevalence of JC virus in MS patients

European journal of clinical microbiology & infectious diseases, 2018-05, Vol.37 (5), p.907-910

2018

Link zum Volltext

Verfügbarkeit prüfen

Kappa-Free Light Chains in CSF Predict Early Multiple Sclerosis Disease Activity

Neurology : neuroimmunology & neuroinflammation, 2021-07, Vol.8 (4)

2021

Link zum Volltext

Verfügbarkeit prüfen

Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity—a cohort study

EBioMedicine, 2023-05, Vol.91, p.104573-104573, Article 104573

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(52)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Low-frequency MR elastography reveals altered deep gray matter viscoelasticity in multiple sclerosis

Smelling multiple sclerosis: Different qualities of olfactory function reflect either inflammatory activity or neurodegeneration

Experiences in treatment of multiple sclerosis with natalizumab from a real-life cohort over 15 years

Change of olfactory function as a marker of inflammatory activity and disability progression in MS

Immune profiling in multiple sclerosis: a single-center study of 65 cytokines, chemokines, and related molecules in cerebrospinal fluid and serum

Influence of physical activity on serum vitamin D levels in people with multiple sclerosis

Cerebrospinal fluid B cells and disease progression in multiple sclerosis - A longitudinal prospective study

Paroxysmal and unusual symptoms as first clinical manifestation of multiple sclerosis do not indicate benign prognosis-The PaSiMS II study

Impact of Disease-Modifying Treatments on the Longitudinal Evolution of Anti-JCV Antibody Index in Multiple Sclerosis

Transient impairment of olfactory threshold in acute multiple sclerosis relapse

Distinct serum and cerebrospinal fluid cytokine and chemokine profiles in autoantibody-associated demyelinating diseases

Evaluation of a self-administered iPad®-based processing speed assessment for people with multiple sclerosis in a clinical routine setting

Pregnancy and multiple sclerosis in the DMT era: A cohort study in Western Austria

Peripapillary retinal nerve fibre layer as measured by optical coherence tomography is a prognostic biomarker not only for physical but also for cognitive disability progression in multiple sclerosis

Macular ganglion cell–inner plexiform layer thinning as a biomarker of disability progression in relapsing multiple sclerosis

Psychological factors and brain magnetic resonance imaging metrics associated with fatigue in persons with multiple sclerosis

Impairment of odor discrimination and identification is associated with disability progression and gray matter atrophy of the olfactory system in MS

Serum neurofilament levels correlate with retinal nerve fiber layer thinning in multiple sclerosis

Retinal layer thinning predicts treatment failure in relapsing multiple sclerosis

Quantifying the risk of disease reactivation after interferon and glatiramer acetate discontinuation in multiple sclerosis: The VIAADISC score

Olfactory threshold predicts treatment response in relapsing multiple sclerosis

Late-onset neutropenia in a multiple sclerosis patient after first dose ocrelizumab switched from rituximab

Smoking is not associated with higher prevalence of JC virus in MS patients

Kappa-Free Light Chains in CSF Predict Early Multiple Sclerosis Disease Activity

Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity—a cohort study

Suchergebnisse filtern